Kyowa Kirin Pharmaceutical Development, Inc

NJ · United States · Reporting entity ID 100000501826

Total reported 2019–2025

$6.72M

#610 of 2,960 reporting companies — 0% of all reported industry payments

$120K in general payments across 27 records, plus $6.60M in research funding across 637 records.

How it breaks down

General payments $120,167

Research funding $6,596,043

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.